Conditions: Prostatic Hyperplasia
Keywords: Benign Prostatic Hyperplasia BPH dutasteride
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 378
Healthy volunteers: no

Brief summary:
This study will assess the efficacy and safety of GI198745 0.5mg given once daily for 52 weeks to Benign Prostatic Hyperplasia (BPH) patients.

Detailed description:

Arms:
arm 1: None arm 2: None

Interventions: intervention 1: Dutasteride intervention 2: Placebo
Intervention descriptions: intervention 1: once daily intervention 2: once daily

Protocol document: